Papadimitriou, M.-A.; Avgeris, M.; Levis, P.; Papasotiriou, E.C.; Kotronopoulos, G.; Stravodimos, K.; Scorilas, A.
tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5′-tRF-LysCTT Results in Disease Early Progression and Patients’ Poor Treatment Outcome. Cancers 2020, 12, 3661.
https://doi.org/10.3390/cancers12123661
AMA Style
Papadimitriou M-A, Avgeris M, Levis P, Papasotiriou EC, Kotronopoulos G, Stravodimos K, Scorilas A.
tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5′-tRF-LysCTT Results in Disease Early Progression and Patients’ Poor Treatment Outcome. Cancers. 2020; 12(12):3661.
https://doi.org/10.3390/cancers12123661
Chicago/Turabian Style
Papadimitriou, Maria-Alexandra, Margaritis Avgeris, Panagiotis Levis, Evangelia Ch. Papasotiriou, Georgios Kotronopoulos, Konstantinos Stravodimos, and Andreas Scorilas.
2020. "tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5′-tRF-LysCTT Results in Disease Early Progression and Patients’ Poor Treatment Outcome" Cancers 12, no. 12: 3661.
https://doi.org/10.3390/cancers12123661
APA Style
Papadimitriou, M.-A., Avgeris, M., Levis, P., Papasotiriou, E. C., Kotronopoulos, G., Stravodimos, K., & Scorilas, A.
(2020). tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5′-tRF-LysCTT Results in Disease Early Progression and Patients’ Poor Treatment Outcome. Cancers, 12(12), 3661.
https://doi.org/10.3390/cancers12123661